Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities and Exchange Act of 1934.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized. This Form 6-K, including all exhibits hereto, is hereby incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of
1933.
|
|
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: Info@camtek.com Web site: http://www.camtek.com
|
|
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
moshee@camtek.com
|
INTERNATIONAL INVESTOR RELATIONS
EK Global Investor Relations
Ehud Helft
Tel: (US) 1 212 378 8040
camtek@ekgir.com
|
FOR IMMEDIATE RELEASE
CAMTEK ANNOUNCES RESULTS FOR THE FIRST QUARTER OF 2024
Q2 revenue guidance of $100-102 million - 37% YoY growth - driven by HBM and Chiplets
MIGDAL HAEMEK, Israel – May 9, 2024 – Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced its financial results for the first quarter, ended March 31, 2024.
Highlights of the First Quarter of 2024
|
• |
Record revenues of $97.0 million, a 34% year-over-year (YoY) increase;
|
|
• |
GAAP operating income of $21.2 million (up 50% YoY) and non-GAAP operating profit of $29.0 million (up 67% YoY), representing operating margins of 21.9% and 29.9%, respectively;
|
|
• |
GAAP net income of $24.8 million and non-GAAP net income of $31.3 million; and
|
|
• |
Strong positive operating cash flow of $20.2 million.
|
Forward-Looking Expectations
Management expects revenues in the second quarter of 2024 between $100-102 million, representing a 37% mid-point increase over the second quarter of
2023. Given the significant visibility and strong ongoing order flow, continued sequential growth is expected throughout 2024.
Management Comment
Rafi Amit, Camtek’s CEO commented, “I am pleased with the record revenues in the first quarter driven by strong demand for HBM and chiplets applications, which accounted for 60% of our business. The field of AI
is changing our industry and Camtek is well positioned to benefit from this transformative trend. AI technology needs High Performance Computing (HPC) capabilities, which are based on architectures utilizing High Bandwidth Memory (HBM) and
Chiplet devices as key components. The on-going surge in demand for HPC and our leading position at all tier-1 manufacturers continue to be the main drivers behind our strong results and outlook.”
Concluded Mr. Amit, “Looking beyond 2024, as AI continues to transform the industry, we are very confident in our ability to capitalize on the trend and grow towards the milestone of annual sales
in excess of $500 million.”
First Quarter 2024 Financial Results
Revenues for the first quarter of 2024 were $97.0 million. This compares to first quarter 2023 revenues of $72.5 million, a year-over-year growth of 34%.
Gross profit on a GAAP basis in the quarter totaled $44.7 million (46.1% of revenues), an increase of 32% compared to a gross profit of $33.9 million (46.7% of revenues) in the first quarter of 2023.
Gross profit on a non-GAAP basis in the quarter totaled $49.1 million (50.6% of revenues), an increase of 43% compared to a gross profit of $34.3 million (47.3% of revenues) in the first quarter of 2023.
Operating profit on a GAAP basis in the quarter totaled $21.2 million (21.9% of revenues), an increase of 50% compared to an operating profit of $14.2 million (19.6% of revenues) in the first
quarter of 2023.
Operating profit on a non-GAAP basis in the quarter totaled $29.0 million (29.9% of revenues), an increase of 67% compared to $17.4 million (24.0% of revenues) in the first quarter of 2023.
Net income on a GAAP basis in the quarter totaled $24.8 million, or $0.51 per diluted share, an increase of 21% compared to net income of $17.2 million, or $0.36 per diluted share, in the first quarter
of 2023.
Net income on a non-GAAP basis in the quarter totaled $31.3 million, or $0.64 per diluted share, an increase of 53% compared to a non-GAAP net income of $20.4 million, or $0.42 per diluted share, in the
first quarter of 2023.
Cash and cash equivalents, short-term and
long-term deposits, and marketable securities, as of March 31, 2024, were $466.3 million compared to $448.6 million as of December 31, 2023. During the first
quarter, the Company generated an operating cash flow of $20.2 million.
Conference Call
Camtek will host a video conference call/webinar today via Zoom, on Thursday, May 9, 2024, at 09:00 ET (16:00 Israel time). Rafi Amit, CEO, Moshe
Eisenberg, CFO, and Ramy Langer, COO will host the call and will be available to answer questions after presenting the results.
To participate in the webinar, please register using the following link, which will provide access to the video call: https://us06web.zoom.us/webinar/register/WN_alZuWboVTLiwN27dla1wKA
For those wishing to listen via phone, following registration, the dial in link will be sent. For any problems in registering, please email Camtek’s
investor relations a few hours in advance of the call.
For those unable to participate, a recording will be available on Camtek’s website at http://www.camtek.com
within a few hours after the call.
A summary presentation of the quarterly results will also be available on Camtek’s website.
ABOUT CAMTEK LTD.
Camtek is a developer and manufacturer of high-end inspection and metrology equipment for the semiconductor industry. Camtek's systems inspect IC and
measure IC features on wafers throughout the production process of semiconductor devices, covering the front and mid-end and up to the beginning of assembly (Post Dicing). Camtek's systems inspect wafers for the most demanding semiconductor market
segments, including Advanced Interconnect Packaging, Heterogenous Integration, Memory and HBM, CMOS Image Sensors, Compound Semiconductors, MEMS, and RF, serving numerous industry's leading global IDMs, OSATs, and foundries.
With manufacturing facilities in Israel and Germany, and eight offices around the world, Camtek provides state of the art solutions in line with
customers' requirements.
This press release is available at http://www.camtek.com
This press release contains statements that may
constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on Camtek’s current beliefs, expectations and assumptions about its business and
industry, all of which may change. Forward-looking statements can be identified by the use of words including “believe,” “anticipate,” “should,” “intend,” “plan,” “will,” “may,” “expect,” “estimate,” “project,” “positioned,” “strategy,” and
similar expressions that are intended to identify forward-looking statements, including statements relating to the compound semiconductors market and our position in this market and the anticipated timing of delivery of the systems. These
forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of Camtek to be materially different from any future results, performance or achievements expressed or
implied by such forward-looking statements. Factors that may cause our actual results to differ materially from those contained in the forward-looking statements include, but are not limited to the effects of the evolving nature of the war
situation in Israel, and the related evolving regional conflicts; the continued demand for HPC, HBM and Chiplet devices resulting from, among
other things, the field of AI surging worldwide across companies, industries and nations; our dependency upon the semiconductor industry and the risk that unfavorable economic conditions or low capital expenditures may negatively impact our
operating results; formal or informal imposition by
countries of new or revised export and/or import and doing-business regulations or sanctions, including but not limited to changes in U.S. trade policies, changes or uncertainty related to the U.S. government entity list and changes in the
ability to sell products incorporating U.S originated technology, which can be made without prior notice, and our ability to effectively address such global trade issues and changes; the risks relating to the concentration of a significant portion of our business in certain countries in the Asia Pacific
Region, particularly China, Taiwan and Korea, some of which might be subject to the trade restrictions referred to above or involved in trade wars with countries which might impose such trade restrictions; changing industry and market trends; and those other factors discussed in our Annual Report on Form 20-F as
published on March 21, 2024, as well as other documents that may be subsequently filed by Camtek from time to time with the Securities and Exchange Commission. We
caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Camtek does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may
arise after the date of this release unless required by law.
While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you
that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. In addition, any forward-looking statements represent Camtek’s views only as of the
date of this press release and should not be relied upon as representing its views as of any subsequent date. Camtek does not assume any obligation to update any forward-looking statements unless required by law.
This press release provides financial measures that exclude: (i) share based compensation expenses; and (ii) acquisition related
expenses and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance. The
presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when
evaluating the business internally and therefore felt it is important to make these non-GAAP adjustments available to investors. A reconciliation between the GAAP and non-GAAP results appears in the tables at the end of this press release. The
results reported in this press-release are preliminary unaudited results, and investors should be aware of possible discrepancies between these results and the audited results to be reported, due to various factors.
Camtek Ltd.
Consolidated Balance Sheets
(In thousands)
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
Assets
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
123,035
|
|
|
|
119,968
|
|
|
Short-term deposits
|
|
|
242,250
|
|
|
|
215,250
|
|
|
Marketable securities
|
|
|
11,941
|
|
|
|
18,816
|
|
|
Trade accounts receivable, net
|
|
|
86,365
|
|
|
|
87,300
|
|
|
Inventories
|
|
|
92,080
|
|
|
|
85,905
|
|
|
Other current assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Long-term deposits
|
|
|
6,000
|
|
|
|
21,000
|
|
|
Marketable securities
|
|
|
83,781
|
|
|
|
73,576
|
|
|
Long-term inventory
|
|
|
9,984
|
|
|
|
9,023
|
|
|
Deferred tax asset, net
|
|
|
2,642
|
|
|
|
2,642
|
|
|
Other assets, net
|
|
|
1,829
|
|
|
|
1,370
|
|
|
Property, plant and equipment, net
|
|
|
42,767
|
|
|
|
41,987
|
|
|
Intangible assets, net
|
|
|
16,030
|
|
|
|
16,937
|
|
|
Goodwill
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total non- current assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Liabilities and shareholders’ equity
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
Trade accounts payable
|
|
|
38,871
|
|
|
|
42,187
|
|
|
Other current liabilities
|
|
|
59,237
|
|
|
|
54,487
|
|
|
Dividend payable
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
158,149
|
|
|
|
96,674
|
|
| |
|
|
|
|
|
|
|
|
|
Long-term liabilities
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities, net
|
|
|
6,368
|
|
|
|
7,541
|
|
|
Other long-term liabilities
|
|
|
11,107
|
|
|
|
10,473
|
|
|
Convertible notes
|
|
|
|
|
|
|
|
|
|
Total long-term liabilities
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Shareholders’ equity
|
|
|
|
|
|
|
|
|
|
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at March 31, 2024 and at December 31, 2023;
|
|
|
|
|
|
|
|
|
|
47,235,723 issued shares at March 31, 2024 and 46,993,998 at December 31, 2023;
|
|
|
|
|
|
|
|
|
|
45,143,347 shares outstanding at March 31, 2024 and 44,901,622 at December 31, 2023
|
|
|
176
|
|
|
|
176
|
|
|
Additional paid-in capital
|
|
|
143,559
|
|
|
|
200,389
|
|
|
Accumulated other comprehensive income (loss)
|
|
|
(410
|
)
|
|
|
129
|
|
|
Retained earnings
|
|
|
|
|
|
|
|
|
| |
|
|
445,476
|
|
|
|
478,046
|
|
|
Treasury stock, at cost (2,092,376 as of March 31, 2024 and December 31, 2023)
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total shareholders' equity
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity
|
|
|
|
|
|
|
|
|
Consolidated Statement of Income (unaudited)
(in thousands, except share data)
| |
|
Three months ended
March 31,
|
|
|
|
|
| |
|
|
|
|
2023
|
|
|
2023
|
|
| |
|
U.S. dollars (In thousands)
|
|
|
Revenues
|
|
|
97,010
|
|
|
|
72,457
|
|
|
|
315,375
|
|
|
Cost of revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
8,912
|
|
|
|
7,554
|
|
|
|
31,470
|
|
|
Selling, general and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
23,485
|
|
|
|
19,669
|
|
|
|
82,221
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial income, net
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before incomes taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net earnings per share (in US dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings per share (in US dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ordinary shares outstanding (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP To Non-GAAP results
(In thousands, except share data)
| |
|
Three months ended
March 31,
|
|
|
|
|
| |
|
2024 |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Reported net income attributable to Camtek Ltd. on GAAP basis
|
|
|
24,799
|
|
|
|
17,245
|
|
|
|
78,632
|
|
|
Acquisition of FRT related expenses (1)
|
|
|
3,384
|
|
|
|
-
|
|
|
|
4,550
|
|
|
Share-based compensation
|
|
|
3,118
|
|
|
|
3,194
|
|
|
|
12,525
|
|
|
Non-GAAP net income
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Non –GAAP net income per share, diluted
|
|
|
0.63
|
|
|
|
0.42
|
|
|
|
1.96
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin on GAAP basis
|
|
|
46.1
|
%
|
|
|
46.7
|
%
|
|
|
46.8
|
%
|
|
Reported gross profit on GAAP basis
|
|
|
44,723
|
|
|
|
33,864
|
|
|
|
147,633
|
|
|
Acquisition of FRT related expenses (1)
|
|
|
3,972
|
|
|
|
-
|
|
|
|
3,492
|
|
|
Share-based compensation
|
|
|
398
|
|
|
|
392
|
|
|
|
1,591
|
|
|
Non-GAAP gross profit
|
|
|
49,093
|
|
|
|
34,256
|
|
|
|
152,716
|
|
|
Non- GAAP gross margin
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported operating profit attributable to Camtek Ltd. on GAAP basis
|
|
|
21,238
|
|
|
|
14,195
|
|
|
|
65,412
|
|
|
Acquisition of FRT related expenses (1)
|
|
|
4,671
|
|
|
|
-
|
|
|
|
5,406
|
|
|
Share-based compensation
|
|
|
3,118
|
|
|
|
3,194
|
|
|
|
12,525
|
|
|
Non-GAAP operating profit
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) During the three-month period ended March 31, 2024, the Company recorded
acquisition-related expenses of $3.4 million, consisting of: (1) inventory written-up to fair value in purchase accounting charges of $3.4 million, for both periods. This amount recorded under cost of revenues line item. (2) $0.6 million
amortization of intangible assets acquired recorded under cost of revenues line item. (3) $0.3 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (4) $0.4 million re-organization expenses,
recorded under the general and administrative expenses line item. (5) $1.3 million reversal
of tax provision related to the above adjustment, recorded under the tax expense line item.
During the year ended December 31, 2024, the Company recorded acquisition expenses of $4.5 million, consisting of: (1) inventory
written-up to fair value in purchase accounting charges of $2.2 million. This amount was recorded under cost of revenues line item. (2) $0.4 million amortization of intangible assets acquired recorded under cost of revenues line item. (3)
Inventory write-off of $0.9 million recorded under costs of revenues line item. (4) $0.2 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (5) Acquisition expenses of $1.7 million recorded
under general and administrative expenses line item. (6) $0.9 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.